Business Context and Reporting Period
Company: Kimberly-Clark Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2006
Business Overview: The Corporation operates four global business segments: Personal Care, Consumer Tissue, K-C Professional & Other, and Health Care. The company is executing a multi-year strategic cost reduction plan aimed at streamlining operations and reducing the workforce by approximately 10% by the end of 2008.
Key Financial Metrics
| Metric (Millions) | Q3 2006 | Q3 2005 | 9M 2006 | 9M 2005 |
|---|---|---|---|---|
| Net Sales | $4,210.4 | $4,000.8 | $12,439.7 | $11,893.7 |
| Gross Profit | $1,275.5 | $1,156.4 | $3,716.2 | $3,785.6 |
| Operating Profit | $526.4 | $464.6 | $1,490.9 | $1,738.4 |
| Net Income | $364.2 | $325.3 | $1,016.9 | $1,197.2 |
| Diluted EPS | $0.79 | $0.68 | $2.21 | $2.49 |
| Cash from Operations | $647.8 (Q3) | N/A | $1,766.5 (9M) | $1,635.7 (9M) |
| Total Debt (Short + Long Term) | $3,632.7 | N/A | $3,632.7 | $3,817.2 (Dec 31, 2005) |
| Cash and Equivalents | $399.2 | N/A | $399.2 | $364.0 (Dec 31, 2005) |
Note: Total Debt calculated as Debt payable within one year ($1,360.6M) plus Long-Term Debt ($2,272.1M) as of Sept 30, 2006.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 5.2% in Q3 2006 and 4.6% for the first nine months, driven by volume growth, price increases, and favorable currency effects (approx. 2% impact in Q3).
- Profitability: Q3 Operating Profit rose 13.3% year-over-year, aided by lower strategic cost reduction charges ($45M less than prior year) and cost savings. However, 9-month Operating Profit declined 14.2% due to significantly higher strategic cost reduction charges ($253.6M increase vs. 2005).
- Net Income: Q3 Net Income increased 12.0% to $364.2M. 9-month Net Income decreased 15.1% to $1,016.9M, impacted by higher restructuring charges and increased stock-based compensation expenses following the adoption of SFAS 123R.
- Segment Performance:
- Personal Care: Sales up 6.7% (Q3) driven by volume growth in North America and emerging markets.
- Consumer Tissue: Sales up 3.1% (Q3) due to price increases, though volumes declined in North America and Europe.
- Health Care: Sales up 7.9% (Q3) with strong volume growth in face masks and gloves.
- Cost Inflation: Raw material costs (fiber, polymers, superabsorbents) and energy costs increased significantly, offsetting some margin gains.
Guidance, Outlook, and Risks
- Strategic Cost Reductions: The company expects cumulative pretax charges of $1.0 to $1.1 billion through 2008, with annual pretax savings of at least $350 million expected in 2009. Full-year 2006 charges are expected to total approximately $500 million.
- Capital Allocation:
- Capital Spending: Targeted between $900 million and $1 billion for the full year 2006.
- Share Repurchases: Targeted at $750 million for the full year 2006. Approximately $464 million spent in the first nine months.
- Dividends: Cash dividends declared were $0.49 per share for Q3 2006.
- Outlook: Management expects solid top-line growth in Q4 driven by emerging markets, price increases, and volume growth. However, inflation (pulp, polymer resins) is expected to continue impacting costs.
- Accounting Changes: Adoption of SFAS 123R (Stock-Based Compensation) reduced net income by $15.6 million for the nine months ended Sept 30, 2006. Adoption of SFAS 158 (Pension Accounting) is expected to increase liabilities by over $350 million upon implementation in 2007.
- Risks: Fluctuations in raw material prices (oil-based products, pulp), foreign currency exchange rates, and competitive pressures on selling prices.
Investor Verification Checklist
- Restructuring Progress: Verify the pace of the strategic cost reduction plan and the realization of the projected $350 million annual savings by 2009.
- Volume Trends: Monitor the rebound in Consumer Tissue volumes in North America and Europe following price increases.
- Input Costs: Track the trajectory of pulp and polymer resin costs, which are currently offsetting margin improvements.
- Equity Affiliate Performance: Review the performance of Kimberly-Clark de Mexico (KCM), which contributed significantly to equity income, and the impact of its recent pulp/paper business sale.
- Debt Levels: Confirm the trajectory of total debt reduction, which stood at $4.4 billion (including preferred securities) as of Sept 30, 2006.